Voltar
Artigo Revisado por pares
BIBTEX RIS

Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study

2011; Springer Science+Business Media; Volume: 30; Issue: 4 Linguagem: Inglês

10.1007/s10637-011-9682-9

ISSN

1573-0646

Autores

Jens Samol, Malcolm Ranson, Edwina N. Scott, Euan Macpherson, James Carmichael, Anne Thomas, James T. Cassidy,

Tópico(s)

Ovarian cancer diagnosis and treatment

Referência(s)